Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001628280-25-050428
Filing Date
2025-11-07
Accepted
2025-11-07 08:05:14
Documents
20
Effectiveness Date
2025-11-07

Document Format Files

Seq Description Document Type Size
1 S-3ASR primemedicine-sx3asrxnovem.htm S-3ASR 519793
2 primeasrfeeexhibit.htm   iXBRL EX-FILING FEES 48704
3 EX-1.2 ex12-sx3asr.htm EX-1.2 276700
4 EX-4.5 ex45-sx3asr.htm EX-4.5 344363
5 EX-4.6 ex46-sx3asr.htm EX-4.6 346767
6 EX-5.1 ex51-sx3asr.htm EX-5.1 15329
7 EX-5.2 ex-52xsx3asr.htm EX-5.2 8013
8 EX-23.1 ex231-sx3asr.htm EX-23.1 1798
9 cover1a.jpg GRAPHIC 30193
  Complete submission text file 0001628280-25-050428.txt   1791099

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT primeasrfeeexhibit_htm.xml XML 16651
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-291348 | Film No.: 251460585
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)